Janek Paul André Frantzén

Direttore/Membro del Consiglio presso BonAlive Biomaterials Oy

Consumer Services

Health Technology

Profilo

Janek Paul André Frantzén is currently a Director at BonAlive Biomaterials Oy.
He obtained a doctorate degree from the University of Bergen in 2001.

Posizioni attive di Janek Paul André Frantzén

Società	Posizione	Inizio
BonAlive Biomaterials Oy BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Janek Paul André Frantzén

Formazione di Janek Paul André Frantzén

University of Bergen

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Janek Paul André Frantzén

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
BonAlive Biomaterials Oy BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland.	Health Technology